Elisabet Cuyàs Navarro
Elisabet Cuyàs Navarro
Girona Biomedical Research Institute (IDIBGi)
Verified email at idibgi.org
Cited by
Cited by
The Warburg effect version 2.0: metabolic reprogramming of cancer stem cells
J MENENDEZ, J Joven, S Cufí, B Corominas-Faja, C Oliveras-Ferraros, ...
Cell cycle 12 (8), 1166-1179, 2013
The anti-malarial chloroquine overcomes primary resistance and restores sensitivity to trastuzumab in HER2-positive breast cancer
S Cufí, A Vazquez-Martin, C Oliveras-Ferraros, B Corominas-Faja, ...
Scientific reports 3, 2469, 2013
Contribution of cytochrome P450 and ABCB1 genetic variability on methadone pharmacokinetics, dose requirements, and response
F Fonseca, R de la Torre, L Díaz, A Pastor, E Cuyàs, N Pizarro, ...
PloS one 6 (5), e19527, 2011
Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway
B Corominas-Faja, S Cufí, C Oliveras-Ferraros, E Cuyàs, E López-Bonet, ...
Cell cycle 12 (18), 3109-3124, 2013
IGF-1R/epithelial-to-mesenchymal transition (EMT) crosstalk suppresses the erlotinib-sensitizing effect of EGFR exon 19 deletion mutations
A Vazquez-Martin, S Cufí, C Oliveras-Ferraros, VZ Torres-Garcia, ...
Scientific reports 3, 2560, 2013
Cell cycle regulation by the nutrient-sensing mammalian target of rapamycin (mTOR) pathway
E Cuyàs, B Corominas-Faja, J Joven, JA Menendez
Cell Cycle Control, 113-144, 2014
Chemical inhibition of acetyl-CoA carboxylase suppresses self-renewal growth of cancer stem cells
B Corominas-Faja, E Cuyàs, J Gumuzio, J Bosch-Barrera, O Leis, ...
Oncotarget 5 (18), 8306, 2014
Stem cell-like ALDHbright cellular states in EGFR-mutant non-small cell lung cancer: A novel mechanism of acquired resistance to erlotinib targetable with the …
B Corominas-Faja, C Oliveras-Ferraros, E Cuyas, A Segura-Carretero, ...
Cell cycle 12 (21), 3390-3404, 2013
Perfectionism dimensions in major postpartum depression
E Gelabert, S Subirà, L García-Esteve, P Navarro, A Plaza, E Cuyàs, ...
Journal of Affective Disorders 136 (1-2), 17-25, 2012
Topography studies on the membrane interaction mechanism of the eosinophil cationic protein
M Torrent, E Cuyás, E Carreras, S Navarro, O López, A De La Maza, ...
Biochemistry 46 (3), 720-733, 2007
Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo
S Cufí, R Bonavia, A Vazquez-Martin, C Oliveras-Ferraros, ...
Scientific reports 3, 2459, 2013
The consequences of 3, 4-methylenedioxymethamphetamine induced CYP2D6 inhibition in humans
B O'Mathúna, M Farré, A Rostami-Hodjegan, J Yang, E Cuyàs, M Torrens, ...
Journal of clinical psychopharmacology 28 (5), 523-529, 2008
Acquired resistance to metformin in breast cancer cells triggers transcriptome reprogramming toward a degradome-related metastatic stem-like profile
C Oliveras-Ferraros, A Vazquez-Martin, E Cuyas, B Corominas-Faja, ...
Cell cycle 13 (7), 1132-1144, 2014
Mitophagy-driven mitochondrial rejuvenation regulates stem cell fate
A Vazquez-Martin, C Van den Haute, S Cufí, B Corominas-Faja, E Cuyàs, ...
Aging (Albany NY) 8 (7), 1330, 2016
Metformin regulates global DNA methylation via mitochondrial one-carbon metabolism
E Cuyàs, S Fernández-Arroyo, S Verdura, RÁF García, J Stursa, L Werner, ...
Oncogene 37 (7), 963-970, 2018
The nutritional phenome of EMT-induced cancer stem-like cells
E Cuyàs, B Corominas-Faja, JA Menendez
Oncotarget 5 (12), 3970, 2014
Silibinin meglumine, a water-soluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR …
S Cufí, R Bonavia, A Vazquez-Martin, B Corominas-Faja, ...
Food and chemical toxicology 60, 360-368, 2013
Clinical pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA,“ecstasy”): the influence of gender and genetics (CYP2D6, COMT, 5-HTT)
R Pardo-Lozano, M Farré, S Yubero-Lahoz, B O’Mathúna, M Torrens, ...
PloS one 7 (10), e47599, 2012
COMT val158met and 5-HTTLPR genetic polymorphisms moderate executive control in cannabis users
A Verdejo-García, AB Fagundo, A Cuenca, J Rodriguez, E Cuyás, ...
Neuropsychopharmacology 38 (8), 1598-1606, 2013
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype
E Cuyàs, S Fernández-Arroyo, B Corominas-Faja, E Rodríguez-Gallego, ...
Oncotarget 6 (14), 12279, 2015
The system can't perform the operation now. Try again later.
Articles 1–20